Oppenheimer Asset Management’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.1M Buy
10,382
+191
+2% +$20.3K 0.01% 725
2025
Q1
$1.27M Buy
10,191
+603
+6% +$74.9K 0.02% 658
2024
Q4
$1.18M Buy
9,588
+1,867
+24% +$230K 0.01% 680
2024
Q3
$860K Sell
7,721
-125
-2% -$13.9K 0.01% 752
2024
Q2
$837K Buy
7,846
+1,272
+19% +$136K 0.01% 745
2024
Q1
$792K Sell
6,574
-820
-11% -$98.7K 0.01% 738
2023
Q4
$909K Sell
7,394
-592
-7% -$72.8K 0.01% 733
2023
Q3
$1.03M Sell
7,986
-49
-0.6% -$6.34K 0.02% 683
2023
Q2
$996K Buy
8,035
+185
+2% +$22.9K 0.01% 703
2023
Q1
$1.15M Buy
7,850
+1,191
+18% +$174K 0.02% 648
2022
Q4
$1.06M Buy
6,659
+42
+0.6% +$6.69K 0.02% 668
2022
Q3
$882K Sell
6,617
-1,120
-14% -$149K 0.02% 687
2022
Q2
$1.21M Sell
7,737
-80
-1% -$12.5K 0.02% 621
2022
Q1
$1.22M Buy
7,817
+557
+8% +$86.7K 0.02% 685
2021
Q4
$925K Buy
7,260
+1,514
+26% +$193K 0.01% 797
2021
Q3
$748K Buy
5,746
+81
+1% +$10.5K 0.01% 826
2021
Q2
$1.01M Buy
5,665
+65
+1% +$11.5K 0.01% 752
2021
Q1
$920K Buy
5,600
+117
+2% +$19.2K 0.01% 755
2020
Q4
$905K Buy
5,483
+244
+5% +$40.3K 0.02% 712
2020
Q3
$747K Buy
5,239
+790
+18% +$113K 0.01% 698
2020
Q2
$491K Sell
4,449
-9,152
-67% -$1.01M 0.01% 797
2020
Q1
$1.36M Buy
13,601
+303
+2% +$30.2K 0.03% 447
2019
Q4
$1.99M Buy
13,298
+494
+4% +$73.7K 0.04% 418
2019
Q3
$1.64M Buy
12,804
+601
+5% +$77K 0.04% 452
2019
Q2
$1.74M Buy
12,203
+161
+1% +$22.9K 0.04% 446
2019
Q1
$1.72M Sell
12,042
-837
-6% -$120K 0.04% 444
2018
Q4
$1.6M Buy
12,879
+1,598
+14% +$198K 0.04% 418
2018
Q3
$1.9M Sell
11,281
-99
-0.9% -$16.6K 0.04% 433
2018
Q2
$1.96M Buy
+11,380
New +$1.96M 0.05% 402
2017
Q3
Sell
-4
Closed -$1K 1697
2017
Q2
$1K Sell
4
-16
-80% -$4K ﹤0.01% 1636
2017
Q1
$3K Buy
+20
New +$3K ﹤0.01% 1619